Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incannex Healthcare (IXHL) Gains from Investment Securities (2023 - 2025)

Incannex Healthcare's Gains from Investment Securities history spans 3 years, with the latest figure at $109335.0 for Q4 2025.

  • For Q4 2025, Gains from Investment Securities fell 53.48% year-over-year to $109335.0; the TTM value through Dec 2025 reached $109335.0, down 53.48%, while the annual FY2025 figure was $227508.0, 3.19% down from the prior year.
  • Gains from Investment Securities for Q4 2025 was $109335.0 at Incannex Healthcare, down from $118173.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $23.6 million in Q2 2025 and bottomed at -$1.8 million in Q1 2025.
  • The 3-year median for Gains from Investment Securities is $235008.0 (2024), against an average of $2.4 million.
  • The largest YoY upside for Gains from Investment Securities was 9961.79% in 2025 against a maximum downside of 742.24% in 2025.
  • A 3-year view of Gains from Investment Securities shows it stood at $349500.0 in 2023, then plummeted by 32.76% to $235008.0 in 2024, then tumbled by 53.48% to $109335.0 in 2025.
  • Per Business Quant, the three most recent readings for IXHL's Gains from Investment Securities are $109335.0 (Q4 2025), $118173.0 (Q3 2025), and $23.6 million (Q2 2025).